Tech Company Financing Transactions

NeuroTherapeutics Pharma Funding Round

NeuroTherapeutics Pharma, based in Chicago, secured $43 million from MPM Capital, SR One Capital Management and F-Prime Capital.

Transaction Overview

Company Name
NeuroTherapeutics Pharma
Announced On
5/20/2010
Transaction Type
Venture Equity
Amount
$43,000,000
Round
Series B
Investors

MPM Capital (Lead Investor) (Luke Evnin)

SR One Capital Management (Lead Investor) (Rajeev Dadoo)

F-Prime Capital (Thomas Beck)

Novo Ventures (Heath Lukatch)

Pfizer Venture Investments (Elaine Jones)

Thomas, McNerny & Partners

Proceeds Purpose
The company's Series B financing will advance NTP-2014 up to and through multiple proof-of-concept Phase II trials and further develop a pipeline to expand this new class of therapy.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
8750 West Bryn Mawr Avenue 440
Chicago, IL 60631
USA
Phone
(773) 444-4180
Website
www.ntprx.com
Email Address
[email protected]
Overview
NeuroTherapeutics Pharma (NTP) is an early stage company focused on the development of therapies for CNS disorders with an initial focus on epilepsy.
Profile
NeuroTherapeutics Pharma LinkedIn Company Profile
Social Media
NeuroTherapeutics Pharma Company Twitter Account
Company News
NeuroTherapeutics Pharma News
Facebook
NeuroTherapeutics Pharma on Facebook
YouTube
NeuroTherapeutics Pharma on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Stephen Collins
  Stephen Collins LinkedIn Profile  Stephen Collins Twitter Account  Stephen Collins News  Stephen Collins on Facebook
Chief Scientific Officer
Michael Venuti
  Michael Venuti LinkedIn Profile  Michael Venuti Twitter Account  Michael Venuti News  Michael Venuti on Facebook
VP - Finance
Brian Williams
  Brian Williams LinkedIn Profile  Brian Williams Twitter Account  Brian Williams News  Brian Williams on Facebook
VP - Operations
Holli Carlson
  Holli Carlson LinkedIn Profile  Holli Carlson Twitter Account  Holli Carlson News  Holli Carlson on Facebook
VP - R & D
Stephen Wanaski
  Stephen Wanaski LinkedIn Profile  Stephen Wanaski Twitter Account  Stephen Wanaski News  Stephen Wanaski on Facebook

 

 

Browse more venture capital transactions:

Prev: 5/20/2010: OurStage venture capital transaction
Next: 5/20/2010: ex.fm venture capital transaction

 

Share this article

 

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. All VC database entries on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.